Literature DB >> 10418279

Poncet's disease in a north Indian hospital.

R Sood1, J P Wali, R Handa.   

Abstract

Although the entity of tuberculous rheumatism or Poncet's disease has sometimes been the subject of debate, it has been reported infrequently in the English literature. We discuss here seven patients (5 women, 2 men; age 18-48 years) who presented primarily with polyarthritis and fever and developed pulmonary, pleural or nodal tuberculosis later in the course of disease. Rheumatoid arthritis, collagen vascular diseases and other common causes of polyarthritis were ruled out by appropriate investigations. Polyarthritis resolved in all the patients after the institution of antitubercular treatment and did not recur, thus providing a therapeutic confirmation of the clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418279     DOI: 10.1177/004947559902900112

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  4 in total

1.  Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis.

Authors:  O Elkayam; R Segal; M Lidgi; D Caspi
Journal:  Ann Rheum Dis       Date:  2005-12-16       Impact factor: 19.103

Review 2.  Clinical features of Poncet's disease. From the description of 198 cases found in the literature.

Authors:  Juan C Rueda; Marie-Francoise Crepy; Rubén D Mantilla
Journal:  Clin Rheumatol       Date:  2013-04-28       Impact factor: 2.980

3.  Poncet's disease: two case reports.

Authors:  Fatima Adhi; Rabia Hasan; Mehreen Adhi; Syed Ali Hamid; Nousheen Iqbal; Javaid A Khan
Journal:  J Med Case Rep       Date:  2017-04-06

4.  Reactive arthritis induced by active extra-articular tuberculosis: A case report.

Authors:  Yushiro Endo; Shin-Ya Kawashiri; Tomohiro Koga; Momoko Okamoto; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.